Indeterminate genotypes of hepatitis C virus by the Abbott RealTime HCV Genotype II assay in Morocco. About eight cases resolved by a sequencing method.

Z Mesbahi, H Kabbaj, H Malki, N Bouihat, M Qrafli, B Belefquih, S Marcil, Dominique CHALLINE, Jean-Michel PAWLOTSKY, Magali BOUVIER-ALIAS, M Seffar,

J Med Virol. 01/08/2018;90(8) : 1352-1357 10.1002/jmv.25191 26/04/2018

Detection of numerous HIV-1/MO recombinants in France.

F De Oliveira, P Cappy, V Lemee, A Moisan, C Pronier, L Bocket, Magali BOUVIER-ALIAS, ML Chaix, E Gault, O Morvan, JD Poveda, V Schneider, M Wirden, E Alessandri-Gradt, T Mourez, JC Plantier,

AIDS 19/06/2018;32(10) : 1289-1299 10.1097/QAD.0000000000001814.

Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen

S Raymond, F Nicot, C Pallier, P Bellecave, A Maillard, MA Trabaud, L Morand-Joubert, A Rodallec, C Amiel, T Mourez, L Bocket, A Beby-Defaux, Magali BOUVIER-ALIAS, S Lambert-Niclot, C Charpentier, B Malve, A Mirand, J Dina, H Le Guillou-Guillemette, S Marque-Juillet, A Signori-Schmuck, F Barin, A Si-Mohamed, V Avettand Fenoel, C Roussel, V Calvez, K Saune, AG Marcelin, Christophe RODRIGUEZ, D Descamps, J Izopet, ANRS AC11 Resistance Study Group

Clin Infect Dis. 02/05/2018;66(10) : 1588-1594 10.1093/cid/cix1070.

A novel standardized deep sequencing-based assay for hepatitis C virus genotype determination.

Christophe RODRIGUEZ, Alexandre SOULIER, Vanessa DEMONTANT, Lila POITEAU, Mélanie MERCIER-DARTY, Magali BOUVIER-ALIAS, Jean-Michel PAWLOTSKY, Stephane CHEVALIEZ,

Sci Rep. 08/03/2018;8(1) : 4180 10.1038/s41598-018-22614-0.

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.

L Assoumou, C Charpentier, P Recordon-Pinson, M Grude, C Pallier, L Morand-Joubert, S Fafi-Kremer, A Krivine, B Montes, V Ferre, Magali BOUVIER-ALIAS, JC Plantier, J Izopet, MA Trabaud, S Yerly, J Dufayard, C Alloui, L Courdavault, H Le Guillou-Guillemette, A Maillard, C Amiel, A Vabret, C Roussel, S Vallet, J Guinard, A Mirand, A Beby-Defaux, F Barin, A Allardet-Servent, R Ait-Namane, M Wirden, C Delaugerre, V Calvez, ML Chaix, D Descamps, S Reigadas,

j Antimicrob Chemother. 01/06/2017;72(6) : 1769-1773 10.1093/jac/dkx042.

Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis

M Bourliere, P Rabiega, N Ganne-Carrie, L Serfaty, P Marcellin, Y Barthe, D Thabut, D Guyader, Christophe HEZODE, M Picon, X Causse, V Leroy, JP Bronowicki, P Carrieri, G Riachi, I Rosa, P Attali, JM Molina, Y Bacq, A Tran, JD Grange, F Zoulim, H Fontaine, L Alric, I Bertucci, Magali BOUVIER-ALIAS, F Carrat,

Lancet Gastroenterol Hepatol. 01/03/2017;2(3) : 177-188 10.1016/S2468-1253(16)30189-3 20/01/2017

25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patients.

A Belle, E Gizard, G Conroy, A Lopez, Magali BOUVIER-ALIAS, S Rouanet, L Peyrin-Biroulet, Jean-Michel PAWLOTSKY, JP Bronowicki,

United European Gastroenterol J. 01/02/2017;5(1) : 69-75 10.1177/2050640616640157. 07/07/2016

Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.

J Bruder Costa, T Dufeu-Duchesne, V Leroy, I Bertucci, Magali BOUVIER-ALIAS, N Pouget, O Brevot-Lutton, M Bourliere, F Zoulim, J Plumas, C Aspord,

PLoS One. 27/06/2016;11(6) : e0158297 10.1371/journal.pone.0158297

Retreatment with sofosbuvir and simeprevir of patients with hepatitis C virus genotype 1 or 4 who previously failed a daclatasvir-containing regimen.

Christophe HEZODE, Stephane CHEVALIEZ, G Scoazec, Alexandre SOULIER, A Varaut, Magali BOUVIER-ALIAS, Isaac RUIZ, F Roudot-Thoraval, A Mallat, Cyrille FERAY, Jean-Michel PAWLOTSKY,

Hepatology 01/06/2016;63(6) : 1809-1816 10.1002/hep.28491 10/03/2016

Multicenter clinical evaluation of the new 3rd generation assay for detection of antibodies against hepatitis C virus on the VIDAS(®) system.

B Seigneres, F Descamps, R Croise, V Barlet, Magali BOUVIER-ALIAS, Stephane CHEVALIEZ, Jean-Michel PAWLOTSKY, W Abdelhady, M Rafik, AM Avellon, JM Echevarria, M Hausmann, JM Dugua,

J Clin Virol. 01/05/2016;78 : 20-26 10.1016/j.jcv.2016.03.001. 04/03/2016